Treatment of Malignant Melanoma
Treatment of Malignant Melanoma
- A 46-year-old Caucasian female presented one year ago with deep ulcerated primary tumor and multiple involved lymph nodes.
- She was diagnosed with stage IIIC melanoma.
- Patient underwent wide local incision and compete lymph node dissection and appeared to be clear of disease.
- Patient decided not to pursue adjuvant therapy after surgery.
- Six months after surgery, she developed abdominal pain.
- Imaging showed multiple masses in the liver, > 1 cm, scattered pulmonary nodules and some enlarged lymph nodes.
- Tumor biopsy confirmed melanoma and mutational analysis showed BRAF V600E mutation.
- The patient is started on dabrafenib 150 mg bid and trametinib 2 mg qd.
Recent Videos
Related Content
Response Time and BRAF Status Factor Into IO Selection for Melanoma
January 29th 2025Article
During a Case-Based Roundtable® event, Thach-Giao Truong, MD, discussed how data from the CheckMate-067 and RELATIVITY-047 affect their choice of therapy for metastatic melanoma in the first article of a 2-part series.
Read More
